AIM2 and gastric cancer: To date, there is only one study that has focused on AIM2 in GC, which demonstrates that AIM2 levels are lower in early GC tissues compared to progressive GC tissues and AIM2 overexpression suppresses GC cell proliferation, migration and invasion20.